Cipla

Cipla chairman and recent UK study hold out a new (sp)ray of hope in the face of acute Remdesivir shortage

Cipla chairman and recent UK study hold out a new (sp)ray of hope in the face of acute Remdesivir shortage

Dr Yusuf Hamied suggests taking budecort or cyclesonide as a prophylactic in advance for a week or 10 days

COVID-19 drug manufacturers Cipla and Zydus Cadila scale up Remdesvir’s production

COVID-19 drug manufacturers Cipla and Zydus Cadila scale up Remdesvir’s production

Indian multinational pharmaceutical company Cipla, one of the manufacturers of Remdesvir in the country, stated that it scaled up product...Read More

Dr Reddy's, Cipla invest in ABCD Technologies

Dr Reddy's, Cipla invest in ABCD Technologies

Drug majors Dr Reddy's Laboratories and Cipla on Wednesday said they have entered into a partnership agreement with ABCD Technologies LLP...Read More

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

For the third consecutive day, the stock market is trading in green. At 12.30 pm, Sensex touched a new high at 50,377.15 points and Nift...Read More

Corona Vaccine Tracker on Dec 16, 2020

Corona Vaccine Tracker on Dec 16, 2020

This column provides latest update from around the world on coronavirus vaccine.

Cipla Q2 net profit up 39% at Rs 659 crore

Cipla Q2 net profit up 39% at Rs 659 crore

Pharma major Cipla on Friday reported a 38.95 per cent rise in its consolidated net profit to Rs 659.35 crore for the quarter ended Septe...Read More

Cipla Q1 net profit up 27% on robust sales

Cipla Q1 net profit up 27% on robust sales

Total revenue from operations for the quarter under consideration stood at Rs 4,346.16 crore. It was Rs 3,989.02 crore for the same perio...Read More

Cipla witnesses 3 senior-level exits including India biz CEO

Cipla witnesses 3 senior-level exits including India biz CEO

The company, however, did not share the reasons for the exits.

Coronavirus in India: Pharmaceutical giant Cipla set to launch Favipiravir to treat COVID-19 patients

Coronavirus in India: Pharmaceutical giant Cipla set to launch Favipiravir to treat COVID-19 patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a co...Read More

Latest Coronavirus Vaccine Update: Cipla launches generic version of remdesivir at Rs 4,000 per vial

Latest Coronavirus Vaccine Update: Cipla launches generic version of remdesivir at Rs 4,000 per vial

Pharma major Cipla on Wednesday said it has launched its generic version of antiviral drug Remdesivir at Rs 4,000 per vial, which is amon...Read More

 Cipla launches generic version of Remdesivir in India at lower rates

Cipla launches generic version of Remdesivir in India at lower rates

Pharma major Cipla on Wednesday said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowes...Read More

Glenmark stocks surge after nod to launch antiviral drug 'Favipiravir' for mild-to-moderate COVID-19 infections

Glenmark stocks surge after nod to launch antiviral drug 'Favipiravir' for mild-to-moderate COVID-19 infections

Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company...Read More

Emergency use of Remdesivir okayed; Cipla and Hetro to produce the drug by June end

Emergency use of Remdesivir okayed; Cipla and Hetro to produce the drug by June end

Mumbai: In a major breakthrough, the Drug Controller General of India has authorised emergency use of Remdesivir vials to treat Covid 19 ...Read More

Cipla to acquire stake worth Rs 9 crore in GoApptiv

Cipla to acquire stake worth Rs 9 crore in GoApptiv

In order to widen reach in the tier three plus towns, pharmaceutical company, Cipla, has decided to acquire a 21.85 per cent stake in GoA...Read More

Cipla files ANDA generic version of GSK’s Advair Diskus for asthma treatment

Cipla files ANDA generic version of GSK’s Advair Diskus for asthma treatment

Global pharmaceutical company, Cipla Limited, has submitted an Abbreviated New Drug Application (ANDA) which is a generic version of GSK’...Read More

Cipla forms JV with Jiangsu Acebright for respiratory medicines in China

Cipla forms JV with Jiangsu Acebright for respiratory medicines in China

Once incorporated, the JV will set up a manufacturing facility in China for local manufactures of respiratory products

Cipla gets USFDA nod for pulmonary arterial hypertension drug

Cipla gets USFDA nod for pulmonary arterial hypertension drug

New Delhi: Drug major Cipla on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) fo...Read More

Cipla to launch cinacalcet hydrochloride tablets in US

Cipla to launch cinacalcet hydrochloride tablets in US

New Delhi: Drug major Cipla and its subsidiary Cipla USA Wednesday announced a phased launch of generic cinacalcet hydrochloride tablets,...Read More

Tussle between Government and Pharma major Cipla, causes 500 children to face shortage of HIV drug

Tussle between Government and Pharma major Cipla, causes 500 children to face shortage of HIV drug

Due to payment tussle between Indian Government and pharmaceutical company Cipla, more than 600 children are affected and deprived from, ...Read More

placeholder

Ahead of earning season, caution prevails in market      

Mumbai : The benchmark Sensex remained range-bound in choppy trade on Monday, ending about 33 points down as investors preferred to stay ...Read More

Free Press Journal

www.freepressjournal.in